Edwards awarded $394 million in heart valve case

17-01-2014

Edwards awarded $394 million in heart valve case

Edwards Lifesciences Corporation secured another victory against its transcatheter heart valve rival Medtronic, whose CoreValve product was found to wilfully infringe one of Edwards’ patents in a verdict handed down on January 15.


Edwards Lifesciences, Medtronic, transcatheter heart valve, damages, medical devices

LSIPR